Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
129M
-
Number of holders
-
324
-
Total 13F shares, excl. options
-
106M
-
Shares change
-
+4.75M
-
Total reported value, excl. options
-
$5.13B
-
Value change
-
+$225M
-
Put/Call ratio
-
0.24
-
Number of buys
-
149
-
Number of sells
-
-161
-
Price
-
$48.23
Significant Holders of NEOGENOMICS INC - Common Stock, $0.01 par value (NEO) as of Q1 2021
387 filings reported holding NEO - NEOGENOMICS INC - Common Stock, $0.01 par value as of Q1 2021.
NEOGENOMICS INC - Common Stock, $0.01 par value (NEO) has 324 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 106M shares
of 129M outstanding shares and own 82.29% of the company stock.
Largest 10 shareholders include BlackRock Inc. (18.7M shares), VANGUARD GROUP INC (12M shares), Artisan Partners Limited Partnership (4.85M shares), Invesco Ltd. (4.82M shares), WELLINGTON MANAGEMENT GROUP LLP (4.35M shares), JANUS HENDERSON GROUP PLC (4.1M shares), STATE STREET CORP (3.3M shares), BROWN ADVISORY INC (3.14M shares), FRED ALGER MANAGEMENT, LLC (2.24M shares), and Kopp Family Office, LLC (2.2M shares).
This table shows the top 324 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.